Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1996 May;104(Suppl 3):683–686. doi: 10.1289/ehp.96104s3683

Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.

M L Cunningham 1, J J Hayward 1, B S Shane 1, K R Tindall 1
PMCID: PMC1469641  PMID: 8781405

Abstract

The aromatic amines 2,4-diaminotoluene (2,4-DAT) and 2,6-diaminotoluene (2,6-DAT) are structural isomers that have been extensively studied for their mutagenic and carcinogenic characteristics. Both compounds are rapidly absorbed after oral administration and are equally mutagenic in the Ames test; however, 2,4-DAT is a potent hepatocarcinogen, whereas 2,6-DAT does not produce an increased incidence of tumors in rats or mice at similar doses. The Big Blue transgenic B6C3F1 mouse carries multiple copies of the lacl mutational target gene. Our studies were designed to determine whether the Big Blue system could be used to detect differences in the vivo mutagenic activity between the carcinogen-noncarcinogen pair 2,4-DAT and 2,6-DAT and to determine whether the in vivo mutagenesis assay results correspond to the rodent carcinogen bioassay results. Male B6C3F1 transgenic mice were exposed to 2,4-DAT or 2,6-DAT at 0 or 1,000 ppm in the diet for 30 and 90 days or to dimethylnitrosamine as a positive control. Mutant frequencies were nearly identical for all three groups at 30 days, while at 90 days the mutant frequency for the hepatocarcinogen 2,4-DAT (12.1 +/- 1.4 x 10(-5)) was significantly higher (p < 0.01) as compared to both age-matched (spontaneous) controls (5.7 +/- 2.9 x 10(-5)) and the 2,6-DAT-exposed group (5.7 +/- 2.4 x 10(-5)). Results from this study demonstrate that the Big Blue transgenic mutation assay can distinguish differences in vivo between the mutagenic responses of hepatic carcinogens ad a noncarcinogen; is sensitive to mutagens through subchronic dietary exposure; and yields a differential response depending upon the length of time mice are exposed to a mutagen.

Full text

PDF
683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cunningham M. L., Burka L. T., Matthews H. B. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen. Drug Metab Dispos. 1989 Nov-Dec;17(6):612–617. [PubMed] [Google Scholar]
  2. Cunningham M. L., Foley J., Maronpot R. R., Matthews H. B. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair--2,6- and 2,4-diaminotoluene. Toxicol Appl Pharmacol. 1991 Mar 1;107(3):562–567. doi: 10.1016/0041-008x(91)90319-a. [DOI] [PubMed] [Google Scholar]
  3. Kohler S. W., Provost G. S., Kretz P. L., Fieck A., Sorge J. A., Short J. M. The use of transgenic mice for short-term, in vivo mutagenicity testing. Genet Anal Tech Appl. 1990 Dec;7(8):212–218. doi: 10.1016/0735-0651(90)90003-x. [DOI] [PubMed] [Google Scholar]
  4. Liu L., Allay E., Dumenco L. L., Gerson S. L. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas. Cancer Res. 1994 Sep 1;54(17):4648–4652. [PubMed] [Google Scholar]
  5. Mirsalis J. C., Provost G. S., Matthews C. D., Hamner R. T., Schindler J. E., O'Loughlin K. G., MacGregor J. T., Short J. M. Induction of hepatic mutations in lacI transgenic mice. Mutagenesis. 1993 May;8(3):265–271. doi: 10.1093/mutage/8.3.265. [DOI] [PubMed] [Google Scholar]
  6. Mirsalis J. C., Tyson C. K., Butterworth B. E. Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay. Environ Mutagen. 1982;4(5):553–562. doi: 10.1002/em.2860040506. [DOI] [PubMed] [Google Scholar]
  7. Morrison V., Ashby J. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays. Mutagenesis. 1994 Jul;9(4):367–375. doi: 10.1093/mutage/9.4.367. [DOI] [PubMed] [Google Scholar]
  8. Piegorsch W. W., Margolin B. H., Shelby M. D., Johnson A., French J. E., Tennant R. W., Tindall K. R. Study design and sample sizes for a lacI transgenic mouse mutation assay. Environ Mol Mutagen. 1995;25(3):231–245. doi: 10.1002/em.2850250310. [DOI] [PubMed] [Google Scholar]
  9. Poound A. W., McGuire L. J. Influence of repeated liver regeneration on hepatic carcinogenesis by diethylnitrosamine in mice. Br J Cancer. 1978 Apr;37(4):595–602. doi: 10.1038/bjc.1978.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Provost G. S., Kretz P. L., Hamner R. T., Matthews C. D., Rogers B. J., Lundberg K. S., Dycaico M. J., Short J. M. Transgenic systems for in vivo mutation analysis. Mutat Res. 1993 Jul;288(1):133–149. doi: 10.1016/0027-5107(93)90215-2. [DOI] [PubMed] [Google Scholar]
  11. Shephard S. E., Sengstag C., Lutz W. K., Schlatter C. Mutations in liver DNA of lacI transgenic mice (Big Blue) following subchronic exposure to 2-acetylaminofluorene. Mutat Res. 1993 Jun;302(2):91–96. doi: 10.1016/0165-7992(93)90009-k. [DOI] [PubMed] [Google Scholar]
  12. Sisk S. C., Pluta L. J., Bond J. A., Recio L. Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis. 1994 Mar;15(3):471–477. doi: 10.1093/carcin/15.3.471. [DOI] [PubMed] [Google Scholar]
  13. Tinwell H., Lefevre P. A., Ashby J. Mutation studies with dimethyl nitrosamine in young and old lac I transgenic mice. Mutat Res. 1994 Jun 1;307(2):501–508. doi: 10.1016/0027-5107(94)90261-5. [DOI] [PubMed] [Google Scholar]
  14. Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen. 1988;11 (Suppl 12):1–157. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES